Memantine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Memantine and local guidelines before prescribing.

NMDA antagonist

Mechanism

NMDA receptor antagonist.

Uses

Moderate to severe Alzheimer disease.

Dosing

Side effects

Dizziness, headache, constipation, hypertension, confusion.

Interactions

Other NMDA antagonists (amantadine, ketamine, dextromethorphan).

Contraindications and cautions

Epilepsy, severe renal impairment

Monitoring

Blood pressure, confusion

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Reduce dose if CrCl below 50

Overdose and reversal

Supportive

Special advice

Titrate slowly; reduce dose in renal impairment; caution in epilepsy.

More from the textbook: uses, cautions and other points
Where it is discussed in the book